Brief: Kamada Announces FDA Approval Of Its New In-House Rabies Virus Neutralization Testing Laboratory
01/06/2026 12:20
BRIEF-Kamada Announces FDA Approval Of Its New In-House Rabies Virus Neutralization Testing Laboratory June 1 (Reuters) - Kamada Ltd KMDA.TA:
KAMADA ANNOUNCES FDA APPROVAL OF ITS NEW IN-HOUSE RABIES VIRUS NEUTRALIZATION TESTING LABORATORY
KAMADA ANNOUNCES FDA APPROVAL OF ITS NEW IN-HOUSE RABIES VIRUS NEUTRALIZATION TESTING LABORATORY
Source text: ID:nGNX57p2Gt
Further company coverage: KMDA.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kamada
See all newsBrief: Kamada Updates On Withholding Tax Procedures On Previously Announced Cash Dividend To Shareholders
Brief: Kamada Announces Planned Transition Of Chief Financial Officer
Brief: Kamada Q2 EPS USD 0.16
Brief: Kamada Announces FDA Approval Of Its New In-House Rabies Virus Neutralization Testing Laboratory
Brief: Kamada Q4 EPS USD 0.06